Founder & COOJon is a former international magazine editor with a strong background in business publications (print and digital) in the Middle East and Australia.
AbbVie (NYSE:ABBV) submitted a regulatory application to the European Medicines Agency for subcutaneous SKYRIZI (risankizumab) induction treatment in adults with moderately to severely active Crohn’s disease.
Ripple said its RLUSD stablecoin crossed US$2 billion in market capitalisation last week.
Retail conglomerate Wesfarmers (ASX:WES) announced plans to expand its K Home format following a 3,000sqm trial.
FinTax completed a seed funding round led by YZi Labs at a US$40 million post-money valuation.
Clinuvel Pharmaceuticals (ASX:CUV) announced its board is considering changing its holding structure to list on the Nasdaq and delist from the ASX.
StarkWare says it completed what it describes as the first quantum-resistant Bitcoin (CRYPTO:BTC) transaction on mainnet.
US spot Bitcoin ETFs recorded US$3.03 billion in August inflows after seven straight positive trading days.
Dallas Fed economists estimate tokenised deposits could reduce US banks’ capacity by about US$700 billion.
A survey found 77% of Americans see cryptocurrency in workplace retirement plans as risky, including 46% who call it very risky.
Mineral Resources (ASX:MIN) reported a record statutory net profit after tax of $1.2 billion for the full year ended June 30.
